-transparent.png){kind=logo}
The concanavalin A-unreactive variants of alpha 1-acid glycoprotein introduced in culture medium of monocytes/macrophages induces the inhibition of thymocyte proliferative activity of interleukin 1. LPS or LPS receptors were not involved in the activity of alpha 1-acid glycoprotein on macrophages. alpha 1-acid glycoprotein did not show any direct effect on thymocytes whereas the monocyte/macrophage-supernatant inhibited the interleukin 1 proliferative effect. The activity of tumor necrosis factor and interleukin 2 was not altered by the alpha 1-acid glycoprotein-macrophage supernatant.
Related Publications
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
June 1990,
Inflammation,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
October 1992,
European journal of immunology,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
January 1989,
Progress in clinical and biological research,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
January 1998,
Neuroimmunomodulation,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
May 1988,
The Journal of biological chemistry,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
December 1988,
The Journal of clinical investigation,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
July 1993,
Clinical immunology and immunopathology,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
November 1993,
Journal of leukocyte biology,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
March 2022,
Molecular pharmaceutics,
P N Bories, and
M Guenounou, and
J Féger, and
E Kodari, and
J Agneray, and
G Durand
February 1995,
Nihon rinsho. Japanese journal of clinical medicine,
